跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
FUROSEMIDE-BAXTER furosemide (frusemide) 50 mg/5 mL solution for injection ampoule - TGA Drug Approval Details
Approvals
/
TGA
/
FUROSEMIDE-BAXTER furosemide (frusemide) 50 mg/5 mL solution for injection ampoule
Approved
STANDARD
FUROSEMIDE-BAXTER furosemide (frusemide) 50 mg/5 mL solution for injection ampoule
Baxter Healthcare Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
f56b8b138290c254
Company
Baxter Healthcare Pty Ltd
Type
Standard
Approval Details
Approval Id
f56b8b138290c254
Product Name
FUROSEMIDE-BAXTER furosemide (frusemide) 50 mg/5 mL solution for injection ampoule
Artg Id
155969
Artg Name
FUROSEMIDE-BAXTER furosemide (frusemide) 50 mg/5 mL solution for injection ampoule
Sponsor
Baxter Healthcare Pty Ltd
Company Detail Path
/organization/baxter-healthcare-pty-ltd
Artg Date
2009-04-03
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Product Information
https://medical-cdn.nocode.com/drug_tga/97dc63176849ca068a4b412be0592d11.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
f56b8b138290c254
Type
Standard
Back to TGA Approvals